Skip to content
GradedGrading live · 2026
LongevityGraded
Menu

Graded review

Function Health vs InsideTracker: Which Lab-Test Membership Wins?

Function casts a wide 100+ marker net; InsideTracker pairs fewer markers with an algorithm. We grade breadth, actionability, price — and who each fits.

Researched & graded by Tom Vance · Lead Reviews Analyst
Last graded
Evidence scorecard

The one-sentence version

These two memberships sell opposite philosophies of the same underlying product. Function Health is a wide net — a flat-priced annual panel of 100+ biomarkers, physician-reviewed, that surfaces a lot and tells you to take it to your doctor. InsideTracker is a narrow funnel — smaller panels plus a one-time DNA layer, an algorithmic "InnerAge" number, and a recommendation engine that turns your results into a to-do list. Neither treats you, both share the same cheap outcome-validated core, and the right pick comes down to a single question: do you want more numbers and the freedom to act on them yourself, or fewer numbers wrapped in an algorithm that pushes specific actions back at you? We grade them below on breadth, actionability, the evidence behind the recommendations, and price. For the full single-service write-ups, see our Function Health review and InsideTracker review.

How we score a head-to-head

We hold both services to the same bar we apply everywhere, laid out in how we grade longevity providers: does a feature change an outcome that matters, and is there evidence it does? That keeps us from rewarding the thing each company most wants you to pay for — a big marker count on one side, a proprietary score and personalized product list on the other. The shared, boring truth is that a handful of cheap markers carry almost all the legitimate value on either platform, and the distinctive features are where the price premiums and the cautions live.

Head-to-head

Function HealthInsideTracker
Marker breadth100+ baseline panel + retestUp to ~43-marker 'Ultimate'
Price shapeFlat ~$499/yr (current market info)Premium per marker (current market info)
Distinctive layerSheer breadth; physician-reviewedDNA kit + InnerAge + recommendations
ActionabilityYou/your clinician interpretAlgorithm pushes specific actions
Useful coreApoB, Lp(a) once, hs-CRP, HbA1cApoB, hs-CRP, HbA1c + deficiency catches
Treats results?No — surfaces and flagsNo — scores and recommends
Two philosophies of the same product: Function's wide flat-priced net versus InsideTracker's smaller, algorithm-driven funnel. Pricing is current market info.

Biomarker breadth: Function wins the count, but the count is mostly framing

On raw breadth Function is the clear winner — a 100+ baseline panel plus a mid-year retest dwarfs InsideTracker's tiers, which top out around a 43-marker "Ultimate" plan. If your instinct is "more data is better," Function looks like the obvious buy.

The catch is that breadth and value are not the same axis. On both platforms, the markers that actually carry hard-outcome evidence are a short list: a cardiovascular particle count, an inflammation marker, a long-term glucose measure, and a few treatable deficiencies. Function's extra 60-odd line items are largely ordinary bloodwork plus a correlated tail that tracks the cheap core without adding much independent signal — and a couple of its featured markers actively mislead as targets, which we cover in the breadth section below. So Function wins "most markers" decisively while winning "most useful markers" only modestly. InsideTracker tests fewer things but isn't meaningfully shorter on the markers that matter.

Actionability: this is InsideTracker's whole pitch — and its biggest conflict

Here the services genuinely diverge. Function hands you a flagged dashboard and stops; the work of interpreting and acting falls entirely to you and your clinician. InsideTracker instead converts your results into specific nutrition, exercise, and supplement recommendations, and frames a subset of markers as an "InnerAge" you're meant to lower. For a buyer who wants to be told what to do, that is a real, tangible difference in experience.

But actionability cuts both ways, and our grade has to weigh the quality of the actions, not just their presence. The InnerAge score is a proprietary composite of your blood markers — not a validated epigenetic clock, and not something proven to extend life when you push it down. And the recommendation engine carries a built-in conflict: the supplement nudges flow from a company that benefits when you act on them. Function's silence is less satisfying but also less conflicted; InsideTracker's guidance is more useful when it's steering you toward diet and exercise, and more suspect when it's steering you toward a bottle. The honest read: InsideTracker is more actionable, but a meaningful share of those actions aren't outcome-backed.

Evidence behind the recommendations: the shared core is solid, the distinctive bits are weaker

Strip away the framing and the evidence picture is nearly identical at the core. Both surface the markers a standard physical skips and that carry genuine hard-outcome data — ApoB, which counts every atherogenic particle and beats LDL-C as a predictor when the two disagree1; hs-CRP, which predicted first cardiovascular events at least as well as LDL cholesterol in a large prospective study2; and HbA1c, which tracked all-cause and cardiovascular mortality continuously across its range3. That core is real on either platform, and it's cheap.

The divergence is in the distinctive layers. Function's "100+" framing leans on markers that mislead as targets — IGF-1 has a U-shaped mortality relationship in meta-analysis, so "raise it to feel younger" is biologically naïve4, and homocysteine looks treatable until you notice that lowering it with B vitamins failed to cut cardiovascular events in randomized trials5. InsideTracker features the same misleading markers and adds a recommendation engine that can pair them with a supplement suggestion. And it's worth saying plainly that the two largest longevity levers in all of epidemiology — cardiorespiratory fitness, among the strongest survival predictors ever measured6, and grip strength, which outpredicted blood pressure across 17 countries in the PURE study7 — sit on neither dashboard. No membership captures them.

Price: different shapes, same lesson

Function's pricing is its cleanest advantage: a flat annual fee (positioned around $499, current market info) for the broad panel and retest, easy to reason about. InsideTracker prices per marker at a premium and stacks retests across annual plans, so you pay more for fewer markers — the money buys the DNA integration and the recommendation layer, not a longer list. If your only goal is getting the cheap outcome-validated core in front of a clinician, Function delivers more raw testing per dollar, and a focused broad panel can undercut both. We map the price-versus-padding trade across the field in the best longevity blood tests.

The verdict

Verdict: Function for breadth and flat price, InsideTracker for guidance, neither if you just want the core cheaply

  • The legitimate value is the same on both — a short list of cheap, outcome-validated markers (ApoB, hs-CRP, HbA1c).
  • Function wins breadth and price clarity, but most of the 100+ count is ordinary bloodwork or correlated padding.
  • InsideTracker wins actionability, but its supplement nudges carry a built-in conflict and InnerAge is not a validated clock.
  • Both feature markers that mislead as targets — IGF-1 (U-shaped mortality) and homocysteine (B-vitamin lowering failed in HOPE-2).
  • Neither treats your results, and neither captures fitness or grip strength — the two biggest longevity levers.
No outright winner: they solve for different buyers, and both share the category limit — they test, they don't treat.

The verdict: who each one is for

Neither service "wins" outright because they're solving for different buyers, and both share the category's defining limit — they test, they don't treat.

Pick Function if you're health-literate, want maximum marker breadth at a predictable flat price, and already have a clinician who will act on an abnormal ApoB or HbA1c. You're buying convenience and coverage, and you're comfortable doing the interpretation yourself.

Pick InsideTracker if you specifically value DNA-informed guidance and want the platform to translate results into steps — and you can keep the supplement nudges at arm's length and treat InnerAge as motivation, not a verdict on how fast you're aging.

Pick neither if your real goal is just the cheap actionable core (ApoB, Lp(a) once, hs-CRP, HbA1c) at the lowest price — a focused panel taken to a clinician beats both, and our tools help you estimate what those markers mean before you spend. For the other most-searched matchup against Function's closest price rival, see Function Health vs Superpower.

Bottom line

Function out-tests InsideTracker on breadth and price clarity; InsideTracker out-guides Function on actionability. But the breadth is mostly framing, the guidance is partly conflicted, and the legitimate value — a short list of cheap, outcome-validated markers — is essentially the same on both. Choose Function for coverage and a flat price you'll interpret yourself; choose InsideTracker for hand-holding you'll have to second-guess. Choose neither if you just want the actionable core cheaply, because that's a focused panel and a clinician, not a subscription.

Frequently asked questions

Function Health vs InsideTracker — which is better?

Neither is better outright; they suit different buyers. Function Health offers far more markers (100+) at a flat annual price and leaves interpretation to you and your clinician. InsideTracker tests fewer markers but layers on DNA, an InnerAge score, and personalized recommendations — at a premium per marker. Choose Function for breadth and price clarity, InsideTracker for guidance you can scrutinize. If you only want the cheap actionable core, a focused panel beats both.

Which has more biomarkers, Function Health or InsideTracker?

Function Health, by a wide margin — a 100+ baseline panel plus a retest, versus InsideTracker's tiers that top out around 43 markers. But more markers isn't more health: on both platforms the genuinely useful, outcome-validated markers are a short list (ApoB, hs-CRP, HbA1c plus a few deficiency catches), and much of Function's extra count is ordinary bloodwork or correlated padding that adds little independent signal.

Does either Function Health or InsideTracker treat your results?

No. Both are measurement products, not clinics. Function surfaces results against optimal ranges and stops; InsideTracker surfaces them, scores an InnerAge, and recommends actions — but neither titrates a statin, builds a managed plan, and rechecks. Acting on an abnormal result falls to you and your own clinician on either platform. That test-but-don't-treat structure is the defining limit of the whole direct-to-consumer lab category.

Is InsideTracker's InnerAge or Function's '100+' worth paying extra for?

Both are the marketing headline more than the value. Function's '100+ biomarkers' inflates the count with ordinary bloodwork and a correlated tail, and features markers (IGF-1, homocysteine) that mislead as targets. InsideTracker's InnerAge is a proprietary composite of your blood markers, not a validated epigenetic clock or a target proven to extend life when lowered. The real value on either platform is the cheap outcome-validated core, not the distinctive feature you're paying a premium for.

References

  1. Glavinovic T, Thanassoulis G, de Graaf J, et al. (2022). Physiological Bases for the Superiority of Apolipoprotein B Over Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk. Journal of the American Heart Association. https://pubmed.ncbi.nlm.nih.gov/36216435/
  2. Ridker PM, Rifai N, Rose L, et al. (2002). Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/12432042/
  3. Khaw KT, Wareham N, Luben R, et al. (2001). Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ. https://pubmed.ncbi.nlm.nih.gov/11141143/
  4. Burgers AM, Biermasz NR, Schoones JW, et al. (2011). Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality. Journal of Clinical Endocrinology & Metabolism. https://pubmed.ncbi.nlm.nih.gov/21795450/
  5. Lonn E, Yusuf S, Arnold MJ, et al. (2006). Homocysteine lowering with folic acid and B vitamins in vascular disease (HOPE-2). New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/16531613/
  6. Mandsager K, Harb S, Cremer P, et al. (2018). Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing. JAMA Network Open. https://pubmed.ncbi.nlm.nih.gov/30646252/
  7. Leong DP, Teo KK, Rangarajan S, et al. (2015). Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. https://pubmed.ncbi.nlm.nih.gov/25982160/

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

More graded reviews